InvestorsHub Logo
Followers 3
Posts 86
Boards Moderated 0
Alias Born 04/02/2020

Re: None

Friday, 05/01/2020 3:17:19 PM

Friday, May 01, 2020 3:17:19 PM

Post# of 424139
I'm expecting (praying) that many of us here will feel more confident once we see Amarin's Opening Brief on Appeal (on or before May 12th whether the appeal is formally expedited by the Fed Circuit or Singer merely files as soon as possible after completing it).

Some of the patent attorneys on this board have done amazingly excellent analyses on the issues and many if not all will be reflected in an organized and concise format that highlights the strongest issues favorable to Amarin, including direct citation to precedent that will be argued to compel reversal. Also, we'll see the benefit of having it be Singer and his crew that is creating the brief---there should be abundant policy reasons set forth in the brief that show why the patent system, policies for innovation, and the practical aspects how despicable decisions like Du's harm everyone all require that the decision be reversed and Amarin's patents be restored. He understands the Hatch/Waxman big picture and can articulate why it doesn't mean that the generics should win every time.

The filing should generate patent expert commentators opinions and analyses, but also set the bar and focus for what the defendants/appellees will have to successfully respond.

Good luck to us all
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News